These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31294807)

  • 1. Low seroprevalence rates of Zika virus in Kuala Lumpur, Malaysia.
    Sam IC; Montoya M; Chua CL; Chan YF; Pastor A; Harris E
    Trans R Soc Trop Med Hyg; 2019 Nov; 113(11):678-684. PubMed ID: 31294807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
    Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
    J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas.
    Nascimento EJM; Bonaparte MI; Luo P; Vincent TS; Hu B; George JK; Áñez G; Noriega F; Zheng L; Huleatt JW
    Am J Trop Med Hyg; 2019 Sep; 101(3):708-715. PubMed ID: 31392955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks.
    Netto EM; Moreira-Soto A; Pedroso C; Höser C; Funk S; Kucharski AJ; Rockstroh A; Kümmerer BM; Sampaio GS; Luz E; Vaz SN; Dias JP; Bastos FA; Cabral R; Kistemann T; Ulbert S; de Lamballerie X; Jaenisch T; Brady OJ; Drosten C; Sarno M; Brites C; Drexler JF
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
    Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated Rapid Active Sampling Surveys Demonstrated a Rapidly Changing Zika Seroprevalence among Children in a Rural Dengue-endemic Region in Southwest Guatemala during the Zika Epidemic (2015-2016).
    Lamb MM; Paniagua-Avila A; Zacarias A; Rojop N; Chacon A; Natrajan MS; Waggoner JJ; Lopez MR; Cordon-Rosales C; Huleatt JW; Bonaparte MI; Asturias EJ; Olson D
    Am J Trop Med Hyg; 2022 Nov; 107(5):1099-1106. PubMed ID: 36252798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low seroprevalence of Zika virus infection among adults in Southern Taiwan.
    Chien YW; Ho TC; Huang PW; Ko NY; Ko WC; Perng GC
    BMC Infect Dis; 2019 Oct; 19(1):884. PubMed ID: 31646973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological Evidence of Widespread Zika Transmission across the Philippines.
    Biggs JR; Sy AK; Brady OJ; Kucharski AJ; Funk S; Tu YH; Reyes MAJ; Quinones MA; Jones-Warner W; Ashall J; Avelino FL; Sucaldito NL; Tandoc AO; Cutiongco-de la Paz E; Capeding MRZ; Padilla CD; Hibberd ML; Hafalla JCR
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperendemic Dengue and Possible Zika Circulation in the Westernmost Region of the Indonesian Archipelago.
    Harapan H; Panta K; Michie A; Ernst T; McCarthy S; Muhsin M; Safarianti S; Zanaria TM; Mudatsir M; Sasmono RT; Imrie A
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
    Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
    J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
    Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of dengue among healthy adults in a rural community in Southern Malaysia: a pilot study.
    Dhanoa A; Hassan SS; Jahan NK; Reidpath DD; Fatt QK; Ahmad MP; Meng CY; Ming LW; Zain AZ; Phipps ME; Othman I; Rabu AB; Sirajudeen R; Fatan AABA; Ghafar FA; Ahmad HB; Allotey P
    Infect Dis Poverty; 2018 Jan; 7(1):1. PubMed ID: 29335021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The seroepidemiology of dengue in a US military population based in Puerto Rico during the early phase of the Zika pandemic.
    Pollett S; Kuklis CH; Barvir DA; Jarman RG; Romaine RM; Forshey BM; Gromowski GD
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009986. PubMed ID: 35061659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.
    Tyson J; Tsai WY; Tsai JJ; Brites C; Mässgård L; Ha Youn H; Pedroso C; Drexler JF; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.